Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.
about
Nonantimicrobial drug targets for Clostridium difficile infections.Fidaxomicin and OP-1118 inhibit C. difficile toxin A- and B-mediated inflammatory responses via inhibition of NF-κB activity.Ceragenin CSA13 Reduces Clostridium difficile Infection in Mice by Modulating the Intestinal Microbiome and Metabolites.Protective Effect of LI05 Against Infection in a Mouse Model
P2860
Probiotic Saccharomyces boulardii CNCM I-745 prevents outbreak-associated Clostridium difficile-associated cecal inflammation in hamsters.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Probiotic Saccharomyces boular ...... ecal inflammation in hamsters.
@en
type
label
Probiotic Saccharomyces boular ...... ecal inflammation in hamsters.
@en
prefLabel
Probiotic Saccharomyces boular ...... ecal inflammation in hamsters.
@en
P2093
P2860
P921
P356
P1476
Probiotic Saccharomyces boular ...... ecal inflammation in hamsters.
@en
P2093
Caroline C Mussatto
Charalabos Pothoulakis
Christina Ortiz
Chunlan Xu
Ciaran P Kelly
Diana Hoang-Ngoc Tran
Elaine C Lee
Hon Wai Koon
Jiani Wang
P2860
P304
P356
10.1152/AJPGI.00150.2016
P577
2016-08-11T00:00:00Z